4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001878824-26-000002
Chief Financial Officer gave up 9,229 shares (to pay taxes)
- Chief Financial Officer acquired 25,719 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| McCombe William D. Chief Financial Officer | 2026-05-18 | Option exercise | +6,320 | 101,007 | D | ||
| McCombe William D. Chief Financial Officer | 2026-05-18 | Shares withheld for taxes | −2,268 | $3.55 | $8,051 | 98,739 | D |
| McCombe William D. Chief Financial Officer | 2026-05-18 | Option exercise | +8,700 | 107,439 | D | ||
| McCombe William D. Chief Financial Officer | 2026-05-18 | Shares withheld for taxes | −3,122 | $3.55 | $11,083 | 104,317 | D |
| McCombe William D. Chief Financial Officer | 2026-05-18 | Option exercise | +10,699 | 115,016 | D | ||
| McCombe William D. Chief Financial Officer | 2026-05-18 | Shares withheld for taxes | −3,839 | $3.55 | $13,628 | 111,177 | D |
| Derivatives | |||||||
| McCombe William D. Chief Financial Officer | 2026-05-18 | Option exercise · Restricted Stock Units | −6,320 | 50,569 | D | ||
| McCombe William D. Chief Financial Officer | 2026-05-18 | Option exercise · Restricted Stock Units | −8,700 | 147,913 | D | ||
| McCombe William D. Chief Financial Officer | 2026-05-18 | Option exercise · Restricted Stock Units | −10,699 | 246,091 | D | ||
Loading xslF345X06/form4-05202026_090502.xml…